The doctor who led development of the first COVID-19 vaccine authorized in the United States, Britain and elsewhere said her company's decision to shift from cancer research to battling the coronavirus happened over breakfast ...
Dec 17, 2020
0
2
No approved vaccine exists for RSV, a life-threatening virus that attacks the respiratory system. State-of-the-art neutron and X-ray scattering performed at the National Institute of Standards and Technology (NIST) may bring ...
Dec 17, 2020
0
4
Progress on a COVID-19 vaccine has propelled the modest husband-and-wife team behind German firm BioNTech into the global limelight, with attention inevitably focussing on their background as the children of Turkish immigrants.
Nov 14, 2020
0
8
Scientific advances have transformed the prevention, treatment and cure of many diseases globally. However, millions of Africans continue to die, endure long periods of illnesses—and suffer negative impacts of diseases ...
Sep 16, 2020
0
2
As the COVID-19 pandemic has swept the world, researchers have published hundreds of papers each week reporting their findings—many of which have not undergone a thorough peer review process to gauge their reliability.
Sep 15, 2020
0
79
Infections pose an increasing risk to hospitalized patients. In collaboration with a number of partners, the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has developed a new therapeutic approach ...
Sep 1, 2020
0
2
To date, Congress has authorized roughly $3 trillion in COVID-19 relief assistance—the largest relief package in history. With more COVID relief money on the way, a new study led by two Brigham Young University business ...
Aug 12, 2020
0
6
Black patients are better represented in taxpayer-funded clinical trials testing new cancer treatments compared to trials run by pharmaceutical companies—although black patients are not fully represented in cancer clinical ...
Jun 22, 2020
0
0
Scientists have used 3-D models to break down the DNA behavior of cancer cells, in a breakthrough new study which could revolutionize treatment for the disease.
May 11, 2020
0
43
Research by Yale SOM's Florian Ederer and Song Ma has shown that companies often purchase competitors, not to acquire their ideas and products, but to shut them down—a phenomenon that they have dubbed "killer acquisitions." ...
Apr 6, 2020
0
0
